News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
117 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (4450)
February (4428)
March (5683)
April (4545)
May (5703)
June (4805)
July (3912)
August (4762)
September (4260)
October (3860)
November (4837)
December (2683)
Day
1 (244)
2 (297)
3 (283)
4 (339)
5 (117)
6 (2)
7 (10)
8 (276)
9 (272)
10 (235)
11 (303)
12 (110)
13 (2)
14 (3)
15 (218)
16 (173)
17 (185)
18 (189)
19 (117)
21 (4)
22 (161)
23 (232)
24 (193)
25 (188)
26 (72)
27 (3)
28 (5)
29 (171)
30 (179)
31 (179)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
21
22
23
24
25
26
27
28
29
30
31
Drug Development
Lundbeck’s Migraine Drug Hits Roadblock in Phase III
Lundbeck revealed that its migraine drug Vyepti failed to demonstrate statistical superiority over placebo at reducing the number of monthly migraine days.
August 19, 2022
·
2 min read
·
Tristan Manalac
FDA
Axsome’s Auvelity Becomes First FDA-Approved Oral NMDA For Major Depressive Disorder
The FDA’s decision on Axsome Therapeutics’ Auvelity is based on positive results from a massive clinical program that covered over 1,100 patients with depression.
August 19, 2022
·
2 min read
·
Vanessa Doctor, RN
Policy
Scientists Report Monkeypox Outbreak was Not Only Preventable, but Expected
Cases of monkeypox infections reported in the latest viral outbreak have surpassed 14,000 in the U.S., according to the CDC. Some scientists believe the outbreak was predictable.
August 19, 2022
·
3 min read
·
Alex Keown
Bio NC
The Top Biopharma Companies Hiring New Grads Across the U.S.
Finding a job right out of college can seem like a daunting task. To help, BioSpace has compiled a list of the top companies hiring new grads for entry-level roles.
August 19, 2022
·
2 min read
·
Rosemary Scott
Drug Development
FDA Weekly Review: Daewoong, Novavax, Preceptis and More
The FDA is busy accepting drug applications, granting specialty designations and approving drugs for market. Here’s a look at this week’s FDA activity.
August 19, 2022
·
3 min read
·
Mark Terry
Drug Development
High Cholesterol, Glucose and Gum Disease linked to Alzheimer’s
New study supports link between Alzheimer’s and other diseases and points out potential risk factors for developing Alzheimer’s later in life.
August 19, 2022
·
4 min read
·
Mark Terry
Business
Biotech Looks to Bounce Back in Second Half of 2022
In the second half of the calendar year, the biopharma industry continues to ascend in mergers and acquisitions, new drug approvals and big investments, indicate market confidence and growth.
August 19, 2022
·
3 min read
·
Mark Terry
Employer Resources
How Reverse Mentorship Disrupts Hierarchy and Improves Outlook
Finding a mentor who can serve as a guide for one’s career is a goal for many young professionals. But reverse mentorship can be just as beneficial, as both parties stand to benefit.
August 19, 2022
·
4 min read
·
Rosemary Scott
Business
Kymera Raises $150 Million to Support Protein Degradation Program
Kymera has raised money through sale of more than 2,769,000 shares of common stock to help support the company’s ongoing clinical and preclinical programs.
August 19, 2022
·
4 min read
·
Alex Keown
Career Advice
What Life Science Job Seekers Need to Know Before Working Outside the U.S.
With so many differences in research and regulation, it’s more important now than ever for job seekers considering moving outside of the U.S. to educate themselves before they make the leap.
August 19, 2022
·
3 min read
·
Franklin Carpenter
1 of 12
Next